![2023](https://hemanext.com/wp-content/uploads/2022/02/2021-CEMARK.png)
![2023](https://hemanext.com/wp-content/uploads/2022/02/2021-CEMARK.png)
![2023](https://hemanext.com/wp-content/uploads/2022/02/2021-CEMARK.png)
2022
Transfusions have begun in EU using RBCs processed and stored with the Hemanext ONE® system in Bergen, Norway as part of a post-market clinical study.![2022](https://hemanext.com/wp-content/uploads/2022/02/AABB-SCPP-Seal-Grayscale.png)
2022
On January 24, 2022, Hemanext announced that its innovative blood processing and storage system has been recognized by the Association for the Advancement of Blood & Biotherapies (“AABB”), a leading international association in transfusion medicine and...![2023](https://hemanext.com/wp-content/uploads/2022/02/2021-CEMARK.png)
2021
On April 13, 2021, Hemanext announced that it had received CE Mark certification for Hemanext ONE® system, clearing the way for the medical device to be sold in European markets. On December 30, 2021, Hemanext submitted the Hemanext ONE® system for marketing...![2019](https://hemanext.com/wp-content/uploads/2020/11/2019.png)